Founderland Logofounderland
the ★ top ★ 100 ★ marketers ★
SavedSearch
FoundersFounders
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Product Launches
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Investment News
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Research & Innovation
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
FoundersFounders
Return

Company Page

Peel Therapeutics

Founders

Avi SchroederJoshua Schiffman

Peel Therapeutics is a clinical-stage biotech company that develops evolution-inspired medicines for cancer and inflammatory diseases. Leveraging hundreds of millions of years of evolutionary biology from elephants, plants, and humans, Peel engineers novel drug candidates including its lead asset PEEL-224, a best-in-class TOP1 inhibitor currently in Phase 1 clinical trials for advanced solid tumors. The company operates multidisciplinary teams across Salt Lake City, Utah and Haifa, Israel.

Company Founded in 2015

Healthtech & Biotech iconHealthtech & Biotech

Articles about Peel Therapeutics

Peel Therapeutics Closes Series A for Nature-Inspired Cancer Drugs

Peel Therapeutics Closes Series A for Nature-Inspired Cancer Drugs

Healthtech & Biotech iconHealthtech & BiotechJun 14, 2026

About

Dreamwell AIContact UsOur Story

Articles

Product LaunchesInvestment NewsResearch & Innovation

founderland

We Use Cookies

We baked up some cookies – the digital kind. They help Draper run like a well-oiled mid-century machine. Some are essential to the experience, others help us tailor things to your taste. We promise, no crumbs on your blazer. Take a moment to choose what works for you.